333638801	333638801	CD	B-NP	O
|	|	NNP	I-NP	O
RH	RH	NNP	I-NP	O
|	|	VBD	B-VP	O
08202666	08202666	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2817931	2817931	CD	B-NP	O
|	|	CC	I-NP	O
5/4/2005	5/4/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2005	9/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/2/2005	10/2/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
LESPERANCE	LESPERANCE	NN	B-NP	O
,	,	,	O	O
RICKIE	RICKIE	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Sick	Sick	NNP	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Delirium	Delirium	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
newly	newly	RB	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Stonerock	Stonerock	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
89-year-old	89-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medication	medication	NN	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
colon	colon	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
embolic	embolic	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
in	in	IN	B-PP	O
3/22	3/22	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
40-50	40-50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
lethargy	lethargy	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
denied	deny	VBD	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	I-NP	O
PND	PND	NN	I-NP	O
or	or	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
120s	120s	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
left	left	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Carotid	Carotid	JJ	B-NP	O
massage	massage	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
blocked	block	VBD	B-VP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
too	too	RB	B-ADJP	O
dangerous	dangerous	JJ	I-ADJP	O
to	to	TO	B-VP	O
pharmacologically	pharmacologically	RB	I-VP	O
convert	convert	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
transvenous	transvenous	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Arthritis	Arthritis	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
prostatectomy	prostatectomy	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
colon	colon	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
partial	partial	JJ	I-NP	O
colectomy	colectomy	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
dementia	dementia	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
MRSA	MRSA	NN	I-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
embolic	embolic	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
in	in	IN	B-PP	O
6/17/05	6/17/05	CD	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Sick	Sick	NNP	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Zyprexa	Zyprexa	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
cigarette	cigarette	NN	B-NP	O
,	,	,	I-NP	O
drug	drug	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
father	father	NN	I-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
63	63	CD	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
colon	colon	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
irregular	irregular	JJ	B-ADJP	O
,	,	,	O	O
125	125	CD	B-NP	O
;	;	:	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/100	140/100	CD	I-NP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
oximetry	oximetry	NN	I-NP	O
was	be	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
male	male	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thyroid	thyroid	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
18	18	CD	B-NP	O
cm	cm	NN	I-NP	O
with	with	IN	B-PP	O
flutter	flutter	NN	B-NP	O
waves	wave	NNS	I-NP	O
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Bibasilar	Bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Irregular	Irregular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Bowel	Bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NNP	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
UPON	UPON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
11.0	11.0	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
40.6	40.6	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
218	218	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
7931	7931	CD	B-NP	O
.	.	.	O	O

Coagulation	Coagulation	NN	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
CK	CK	NN	I-NP	B-protein
of	of	IN	B-PP	O
129	129	CD	B-NP	O
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
of	of	IN	B-PP	O
5.9	5.9	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
troponin	troponin	NN	I-NP	O
at	at	IN	B-PP	O
0.27	0.27	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
,	,	,	O	O
rate	rate	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
120s	120	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
new	new	JJ	B-NP	O
left	left	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NNP	I-NP	O
:	:	:	O	O
Cardiomegaly	Cardiomegaly	NNP	B-NP	O
and	and	CC	O	O
cephalization	cephalization	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
UPON	UPON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
89-year-old	89-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation/atrial	fibrillation/atrial	JJ	I-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
decompensated	decompensate	VBN	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
sick	sick	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
left	left	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O
for	for	IN	B-PP	O
asystole	asystole	NN	B-NP	O
and	and	CC	O	O
symptomatic	symptomatic	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
blocking	block	VBG	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
transvenous	transvenous	JJ	B-NP	O
pacer	pacer	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Cath	Cath	NNP	I-NP	O
Lab	Lab	NNP	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
a.	a.	NN	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
Shortly	Shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temporary	temporary	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
50	50	CD	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
20s	20s	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
intermittently	intermittently	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
digoxin	digoxin	NN	I-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/6/05	6/6/05	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
dual-chamber	dual-chamber	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
implanted	implant	VBN	I-VP	O
with	with	IN	B-PP	O
VVI	VVI	NN	B-NP	B-protein
at	at	IN	B-PP	O
50	50	CD	B-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
on	on	IN	B-PP	O
8/22/05	8/22/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ventricularly	ventricularly	RB	I-VP	O
paced	pace	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
DDD	DDD	NN	B-NP	O
on	on	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
dual-paced	dual-paced	JJ	B-ADJP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
arrhythmias	arrhythmia	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
2.9	2.9	CD	B-NP	O
g	g	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
continued	continue	VBD	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
load	load	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
g.	g.	NN	I-NP	O
b.	b.	NN	I-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
5/23/05	5/23/05	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
regional	regional	JJ	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intraventricular	intraventricular	JJ	I-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
akinetic	akinetic	JJ	B-ADJP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
global	global	JJ	B-NP	O
hyperkinesis	hyperkinesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
indications	indication	NNS	B-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
increased	increase	VBN	B-NP	O
JVP	JVP	NN	I-NP	B-protein
and	and	CC	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
pulmonary	pulmonary	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
effectively	effectively	RB	B-ADVP	O
with	with	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
IV	IV	CD	I-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
91	91	CD	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
87	87	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
intermittent	intermittent	JJ	B-NP	O
Lasix	Lasix	NNP	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
I	I	NNP	I-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
of	of	IN	B-PP	O
500	500	CD	B-NP	O
mL	mL	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
require	require	VB	I-VP	O
continued	continued	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
marked	mark	VBN	I-VP	O
hypertension	hypertension	NN	B-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
occasionally	occasionally	RB	B-ADVP	O
difficulty	difficulty	NN	B-NP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
required	require	VBD	B-VP	O
IV	IV	CD	B-NP	O
nitro	nitro	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

Systolic	Systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	B-PP	O
as	as	RB	B-ADVP	O
high	high	JJ	I-ADVP	O
as	as	IN	B-PP	O
180	180	CD	B-NP	O
and	and	CC	O	O
as	as	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
as	as	IN	B-PP	O
100	100	CD	B-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
nitro	nitro	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	B-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
p.o.	p.o.	NN	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
diltiazem	diltiazem	NN	B-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
360	360	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
110	110	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
120s	120s	CD	B-NP	I-DNA
.	.	.	O	O

c.	c.	NN	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
enzyme	enzyme	NN	I-NP	O
elevation	elevation	NN	I-NP	O
with	with	IN	B-PP	O
initially	initially	RB	B-NP	O
0.27	0.27	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
elevated	elevate	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
max	max	NN	I-NP	O
of	of	IN	B-PP	O
1.27	1.27	CD	B-NP	O
on	on	IN	B-PP	O
10/23/05	10/23/05	CD	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
were	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
2/25/05	2/25/05	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
two-vessel	two-vessel	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
specifically	specifically	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
LAD	LAD	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
diffuse	diffuse	JJ	B-NP	O
proximal-mid	proximal-mid	JJ	I-NP	O
standing	standing	NN	I-NP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
RTLV-BR	RTLV-BR	NN	B-NP	B-protein
mid	mid	IN	B-PP	O
discrete	discrete	JJ	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
beyond	beyond	IN	B-PP	O
the	the	DT	B-NP	O
bifurcation	bifurcation	NN	I-NP	O
of	of	IN	B-PP	O
RPDA	RPDA	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
2/25/05	2/25/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
successful	successful	JJ	I-NP	O
roto-ablation	roto-ablation	NN	I-NP	O
,	,	,	O	O
angioplasty	angioplasty	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
cipher	cipher	NN	I-NP	O
DES	DES	NNP	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
TIMI	TIMI	NN	B-NP	O
2	2	CD	I-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
lab	lab	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
DES	DES	NNP	I-NP	O
placement	placement	NN	I-NP	O
at	at	IN	B-PP	O
distal	distal	JJ	B-NP	O
RCA	RCA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
confused	confuse	VBN	I-VP	O
and	and	CC	O	O
somewhat	somewhat	RB	B-VP	O
agitated	agitate	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
behavior	behavior	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Haldol	Haldol	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
p.r.n.	p.r.n.	NN	B-NP	O
Ativan	Ativan	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
confusion	confusion	NN	I-NP	O
and	and	CC	I-NP	O
delirium	delirium	NN	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Haldol	Haldol	NN	I-NP	O
and	and	CC	I-NP	O
Ativan	Ativan	NN	I-NP	O
were	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
off	off	RB	B-PRT	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
reinitiated	reinitiate	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Zyprexa	Zyprexa	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
longstanding	longstanding	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
dementia	dementia	NN	B-NP	O
.	.	.	O	O

Geriatrics	Geriatric	NNS	B-NP	O
consult	consult	NN	I-NP	O
followed	follow	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
case	case	NN	I-NP	O
and	and	CC	O	O
advised	advise	VBN	B-VP	O
on	on	IN	B-PP	O
titration	titration	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Haldol	Haldol	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
Following	Follow	VBG	B-VP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
vacular	vacular	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
7/18/05	7/18/05	CD	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2.9	2.9	CD	B-NP	O
and	and	CC	O	O
became	become	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
supratherapeutic	supratherapeutic	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
reinitiated	reinitiate	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
below	below	IN	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
INR	INR	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
between	between	IN	B-NP	O
2	2	CD	I-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Synthroid	Synthroid	JJ	B-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Thyroid	Thyroid	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
fasting	fast	VBG	I-NP	O
blood	blood	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
95	95	CD	B-NP	O
to	to	TO	B-PP	O
182	182	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	B-protein
sliding	slide	VBG	I-NP	I-protein
scale	scale	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	O	O
required	require	VBD	B-VP	O
only	only	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
supplemental	supplemental	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
significant	significant	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
Colace	Colace	NNP	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Dulcolax	Dulcolax	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stools	stool	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
with	with	IN	B-PP	O
additional	additional	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
colon	colon	NN	B-NP	O
cancer	cancer	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
colectomy	colectomy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
2-liter	2-liter	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
2	2	CD	B-NP	O
g	g	NN	I-NP	O
salt	salt	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low-cholesterol	low-cholesterol	NN	I-NP	O
,	,	,	O	O
low-salt	low-salt	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
mild	mild	JJ	I-NP	O
sedation	sedation	NN	I-NP	O
with	with	IN	B-PP	O
Haldol	Haldol	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
speech	speech	NN	B-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
and	and	CC	O	O
initially	initially	RB	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
honey-thick	honey-thick	JJ	I-NP	O
liquids	liquid	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
his	his	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
house	house	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
low-cholesterol	low-cholesterol	NN	B-NP	O
,	,	,	O	O
low-fat	low-fat	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
salt	salt	NN	I-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
restrictions	restriction	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
light	light	JJ	B-NP	O
scale	scale	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
urinalysis	urinalysis	NN	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
culture	culture	NN	I-NP	O
remained	remain	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
following	follow	VBG	B-PP	O
on	on	IN	B-PP	O
pacemaker	pacemaker	NN	B-NP	O
placement	placement	NN	I-NP	O
for	for	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
infection	infection	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

COMPLICATIONS	COMPLICATIONS	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

CONSULTANTS	CONSULTANTS	NNS	B-NP	O
:	:	:	O	O
EP	EP	NN	B-NP	O
fellow	fellow	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Brosi	Brosi	NNP	I-NP	O
attending	attend	VBG	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Pizzitola	Pizzitola	NNP	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	JJ	I-NP	O
elderly	elderly	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normocephalic	Normocephalic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
atraumatic	atraumatic	JJ	I-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
motions	motion	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
9	9	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	NNP	B-NP	O
:	:	:	O	O
Sparse	Sparse	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
that	that	WDT	B-NP	O
cleared	clear	VBD	B-VP	O
with	with	IN	B-PP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Trace	Trace	NN	B-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

Pedal	Pedal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Cranial	Cranial	NNP	B-NP	O
nerves	nerve	NNS	I-NP	O
II-XII	II-XII	CD	B-NP	O
are	be	VBP	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
include	include	VB	I-VP	O
discharge	discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
follow-up	follow-up	JJ	B-NP	O
plans	plan	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-4350473	9-4350473	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DERN	DERN	NN	B-NP	O
,	,	,	O	O
CASEY	CASEY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NEAULT	NEAULT	NNP	B-NP	O
,	,	,	O	O
KIETH	KIETH	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2077505	2077505	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/18/05	7/18/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/18/05	7/18/05	CD	B-NP	O

